| Q51969760 | Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis. |
| Q31095554 | Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia? |
| Q50993509 | Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings. |
| Q37643444 | Cannabis use and cognition in schizophrenia |
| Q51888329 | Cannabis use and neuropsychological performance in healthy individuals and patients with schizophrenia. |
| Q33985743 | Cannabis use disorders in schizophrenia: effects on cognition and symptoms |
| Q47945952 | Cognitive functioning associated with stimulant use in patients with non-affective psychosis, their unaffected siblings and healthy controls |
| Q38401669 | Comorbid substance abuse and neurocognitive function in recent-onset schizophrenia |
| Q38124448 | Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings |
| Q46857400 | Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorder |
| Q37285509 | Evaluating the relationship between cannabis use and IQ in youth and young adults at clinical high risk of psychosis |
| Q39517216 | Executive functioning in individuals with schizophrenia and/or cocaine dependence. |
| Q47980330 | Facial emotion recognition in schizophrenia: An exploratory study on the role of comorbid alcohol and substance use disorders and COMT Val158Met |
| Q47439536 | Heavy cannabis use prior psychosis in schizophrenia: clinical, cognitive and neurological evidences for a new endophenotype? |
| Q36577094 | Inferior performance on selected neuropsychological tests in abstinent schizophrenia patients who have used cannabis. |
| Q43872699 | Lifetime cannabis use and cognition in patients with schizophrenia spectrum disorders and their unaffected siblings. |
| Q36959030 | Naturalistic follow-up of co-morbid substance use in schizophrenia: the West London first-episode study |
| Q31027922 | Neurobiological correlates of violent behavior among persons with schizophrenia |
| Q36393831 | Neurocognitive features in male patients with schizophrenia exhibiting serious violence: a case control study |
| Q33762494 | Neurocognitive functioning of individuals with schizophrenia: using and not using drugs |
| Q33901507 | Neurological soft signs in Tunisian patients with first-episode psychosis and relation with cannabis use |
| Q51861083 | Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia. |
| Q39577163 | Predictors of community functioning in schizophrenia and substance use disorder patients |
| Q46478883 | Processing of social emotion in patients with schizophrenia and substance use disorder: an fMRI study |
| Q36281966 | Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome |
| Q34531537 | The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability |
| Q29013516 | The Neuropsychology of Sex Offenders: A Meta-Analysis |
| Q36386484 | The Role of Endocannabinoid Signaling in Cortical Inhibitory Neuron Dysfunction in Schizophrenia |
| Q33641039 | The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample |
| Q37061404 | The neural correlates of mental rotation abilities in cannabis-abusing patients with schizophrenia: an FMRI study |
| Q36965847 | The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues |
| Q37022580 | Violent behaviour among people with schizophrenia: a framework for investigations of causes, and effective treatment, and prevention |
| Q51952571 | Working memory and depressive symptoms in patients with schizophrenia and substance use disorders. |